Investing
Top Analyst Upgrades (AKAM, BSX, CLX, CVA, ESRX, MCRS, PRXL, PFE, QSII, SGMS)
Published:
Last Updated:
These are some of the top analyst upgrades and positive calls we are seeing this Monday morning:
- Akamai (AKAM) Raised to Buy at Merriman Curhan Ford.
- Boston Scientific (BSX) Raised to Overweight at Thomas Weisel.
- Clorox (CLX) Raised to Buy at Goldman Sachs.
- Covanta (CVA) Raised to Overweight at JPMorgan.
- Express Scripts (ESRX) Raised to Buy at Goldman Sachs.
- Micros Systems (MCRS) Started as Outperform at Oppenheimer.
- PAREXEL (PRXL) Raised to Outperform at Wachovia.
- Pfizer (PFE) Raised to Outperform at Credit Suisse.
- Quality Systems (QSII) Raised to Buy at Piper Jaffray.
- Scientific Games (SGMS) Raised to Buy at Goldman Sachs.
Jon C. Ogg
February 2, 2009
Sponsored: Want to Retire Early? Here’s a Great First Step
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
